News about Global Pharma

BioCryst Announces Approval of ORLADEYO from Brazilian Health Regulatory Agency

BioCryst Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults.

Global Pharma | 20/04/2024 | By Aishwarya |  546

ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment

ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.

Global Pharma | 19/04/2024 | By Aishwarya |  1078

Scopio Labs Receives FDA Clearance for Full-Field Bone Marrow Aspirate Application

This clearance establishes a new regulatory category for all-digital bone marrow aspirate analysis software, heralding a transformative era in hematologic diagnostics.

Global Pharma | 19/04/2024 | By Abha |  633

Jubilant Generics Limited's Roorkee Facility Receives VAI Classification from USFDA

This classification signifies that the facility is deemed to be in an acceptable state of compliance with current good manufacturing practices (cGMP).

Global Pharma | 19/04/2024 | By Abha |  870

CDSCO Issues Guidelines to Curb Circulation of Substandard Pharmaceuticals

Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines on good distribution practices to curb the introduction of spurious, adulterated and sub-standard pharmaceutical products in the market.

Global Pharma | 19/04/2024 | By Aishwarya |  1233

Biocon Signs Exclusive Licensing and Supply Deal with Biomm for Drug Commercialization

Biocon Limited has signed an exclusive licensing and supply agreement with Biomm to commercialize its vertically integrated drug product, Semaglutide (gOzempic).

Global Pharma | 19/04/2024 | By Aishwarya |  795

Ferring Signs Commercial Gene Therapy Manufacturing Deal with SK pharmteco

Ferring Pharmaceuticals has inked an agreement with SK pharmteco to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin.

Global Pharma | 19/04/2024 | By Aishwarya |  561

OrthoIndy Introduces Augmented Reality into Surgical Procedures

OrthoIndy has announced a monumental step forward in surgical innovation by introducing augmented reality (AR) into surgical procedures.

Global Pharma | 18/04/2024 | By Manvi |  426

HealthSignals Secures Telehealth Agreement with Premier

Committed to enhancing the quality of care, HealthSignals provides facilities with essential tools that prioritize security, reliability, and effective communication and collaboration for telehealth and telemedicine applications.

Global Pharma | 18/04/2024 | By Manvi |  426

X-Therma's XT-Thrive Receives FDA Acceptance for Key Drug Master File

This milestone covers the Chemistry, Manufacturing, and Controls (CMC) for XT-Thrive®, a revolutionary cryopreservation solution enabling non-toxic preservation for life-saving regenerative medicines.

Global Pharma | 18/04/2024 | By Abha |  781